Royal Bank of Canada’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Royal Bank of Canada’s Portfolio XAGE Stock Details XAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,497	Closed	-$4K	–	7657
2025 Q2	$4K	Buy	1,497 +1,484	+11,415%	+$5.42K	﹤0.01%	6712
2025 Q1	$0	Buy	+13	New	+$126	﹤0.01%	7353
2024 Q4	–	Sell	-3	Closed	–	–	7355
2024 Q3	$0	Buy	+3	New	+$82	﹤0.01%	7608
2024 Q2	–	Sell	-7	Closed	-$1K	–	7649
2024 Q1	$1K	Buy	7 +5	+250%	+$474	﹤0.01%	6896
2023 Q4	$0	Buy	+2	New	+$171	﹤0.01%	7689

Other funds holding XAGE

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

CMU

Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return

BSB

Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return

Royal Bank of Canada's XAGE Position: Q3 2025 in Review

Royal Bank of Canada sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2025, closing a stake of 1,497 shares — an estimated $4K sold.

Royal Bank of Canada first reported a position in XAGE in Q4 2023 and held it in 5 quarters. The position peaked at $4K in Q2 2025. 3 funds tracked by Wall St. Rank hold XAGE as of Q3 2025.

Royal Bank of Canada reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
Royal Bank of Canada sold 1,497 Longevity Health Holdings, Inc. Common Stock shares in Q3 2025, an estimated $4K.
Royal Bank of Canada first reported a position in Longevity Health Holdings, Inc. Common Stock in Q4 2023 and held it in 5 quarters.
Royal Bank of Canada's Longevity Health Holdings, Inc. Common Stock position peaked at $4K in Q2 2025.
3 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2025.

Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.